RVL Pharmaceuticals plc

Ownership Transactions Reported by 18 Insiders

Symbol
RVLPQ on OTC
Industry
Pharmaceutical Preparations
Location
400 Crossing Boulevard, Bridgewater, NJ

There are no Buy or Sell transactions made by insiders since 2/3/2024

RVL Pharmaceuticals plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Avista Healthcare Partners, L.P. 10%+ Owner $773K Aug 8, 2022
Athyrium Opportunities IV Acquisition 2 LP 10%+ Owner $201K Aug 8, 2022
Altchem Ltd 10%+ Owner $191K Oct 19, 2023
Harsaul Foundation 10%+ Owner $154K Oct 19, 2023
Brian A. Markison Chief Executive Officer, Director $92.9K Aug 8, 2022
James Schaub EVP and COO $16.4K May 18, 2023
Christopher Klein General Counsel & Secretary $5.63K May 18, 2023
Andrew J. Einhorn Chief Financial Officer $5.13K Jan 24, 2022
Tina Marie deVries EVP, Research & Development $4.25K May 18, 2022
Fred G. Weiss Director $3.7K Aug 27, 2021
Alisa Lask Director $3.51K Aug 10, 2023
Gregory L. Cowan Director $2.81K Jul 5, 2023
Michael J. DeBiasi Director $1.25K Jul 5, 2023
David Burgstahler Director, 10%+ Owner Jan 27, 2023
Avista Capital Partners III GP, L.P. 10%+ Owner Jan 27, 2023
Michael DePetris Principal Accounting Officer Apr 18, 2022
Avista Healthcare Partners GP, Ltd. 10%+ Owner Aug 15, 2023
Sriram Venkataraman Director, 10%+ Owner Jan 27, 2023

Recent Insider Transactions by Companies or Individuals for RVL Pharmaceuticals plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.